i-SENS, Inc.

KOSDAQ:A099190 Voorraadrapport

Marktkapitalisatie: ₩514.0b

i-SENS Inkomsten in het verleden

Verleden criteriumcontroles 0/6

i-SENS's earnings have been declining at an average annual rate of -30.9%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 8.8% per year.

Belangrijke informatie

-30.9%

Groei van de winst

-30.9%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie22.7%
Inkomstengroei8.8%
Rendement op eigen vermogen-1.2%
Nettomarge-1.3%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Mar 27
i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 15
Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Recent updates

i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 05
i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Mar 27
i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

May 07
Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?

Mar 29
Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Mar 16
Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?

Mar 01
Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?

Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?

Feb 14
Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?

How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?

Jan 31
How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

Jan 18
If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Jan 05
Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

Dec 24
Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 15
Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Dec 02
i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Nov 20
Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Opbrengsten en kosten

Hoe i-SENS geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

KOSDAQ:A099190 Opbrengsten, kosten en inkomsten (KRW Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24280,288-3,53171,01730,053
31 Mar 24272,877-76667,22227,780
31 Dec 23265,1203,70962,70026,995
30 Sep 23255,9134,84360,04927,380
30 Jun 23257,3877,69655,01127,205
31 Mar 23256,6617,35254,09627,170
31 Dec 22264,83716,13853,63126,974
30 Sep 22262,06720,07849,01325,364
30 Jun 22252,56225,05946,84223,708
31 Mar 22249,17831,50444,73823,399
31 Dec 21232,93525,45141,79821,891
30 Sep 21225,75829,92344,07220,652
30 Jun 21217,29329,02242,04419,705
31 Mar 21211,66727,28642,03519,316
31 Dec 20203,70826,83941,67218,915
30 Sep 20201,81717,60638,02019,166
30 Jun 20199,98019,87838,00317,951
31 Mar 20193,52824,73336,74216,484
31 Dec 19189,84423,42635,64315,918
30 Sep 19184,13933,94933,97214,473
30 Jun 19181,10932,28734,65314,238
31 Mar 19175,62724,62235,22813,866
31 Dec 18172,99722,61934,62013,352
30 Sep 18168,33318,24735,14713,816
30 Jun 18162,79515,45032,64713,877
31 Mar 18159,32016,43730,15913,779
31 Dec 17156,96415,73029,69413,607
30 Sep 17150,72516,80827,14613,134
30 Jun 17144,10818,05025,40112,484
31 Mar 17139,70916,29524,52512,305
31 Dec 16132,46817,56122,39911,833
30 Sep 16121,64017,06619,67011,486
30 Jun 16113,58315,07418,64911,001
31 Mar 16107,80415,69216,64410,372
31 Dec 15101,92114,71614,7579,794
30 Sep 15100,07413,73615,0659,127
30 Jun 1597,31714,03613,5118,690
31 Mar 1595,55314,04912,9498,619
31 Dec 1495,60814,46612,4458,540
30 Sep 1493,51516,32211,0028,230
30 Jun 1491,05918,23910,3107,899
31 Mar 1486,72018,6469,7297,049
31 Dec 1382,86318,6429,3456,299

Kwaliteitswinsten: A099190 is currently unprofitable.

Groeiende winstmarge: A099190 is currently unprofitable.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: A099190 is unprofitable, and losses have increased over the past 5 years at a rate of 30.9% per year.

Versnelling van de groei: Unable to compare A099190's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: A099190 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4%).

Rendement op eigen vermogen

Hoge ROE: A099190 has a negative Return on Equity (-1.2%), as it is currently unprofitable.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y